News from abide therapeutics

Feb 28, 2014, 08:00 ET
Abide Therapeutics.  (PRNewsFoto/Abide Therapeutics)

Abide Therapeutics Announces Strategic Drug Discovery Collaboration with Celgene Corporation to Advance Treatment Paradigm for Patients with Immune Disorders

 Abide Therapeutics today announced it has entered into a strategic collaboration with Celgene Corporation to discover and develop new drugs...

Oct 29, 2013, 08:00 ET
Abide Therapeutics.  (PRNewsFoto/Abide Therapeutics)

Abide Therapeutics Appoints Dr. Gary O'Neill as Vice President of Biology

 Abide Therapeutics announces today that Gary O'Neill, Ph.D., has joined Abide Therapeutics as vice president of biology and member of the...

Jul 16, 2013, 08:00 ET
Abide Therapeutics.  (PRNewsFoto/Abide Therapeutics)

Abide Therapeutics and UC San Diego Awarded Grant from Cure Alzheimer's Fund to Validate Therapeutic Target

Confirming an enzyme in the serine hydrolase family as a therapeutic target to slow and potentially reverse the effects of Down syndrome and...

May 02, 2013, 07:30 ET
Abide Therapeutics.  (PRNewsFoto/Abide Therapeutics)

Abide Therapeutics Announces Collaboration With Merck to Develop Novel Therapies for Type 2 Diabetes and Metabolic Diseases

 Abide Therapeutics, a biopharmaceutical company pioneering innovative approaches to selectively target a group of enzymes known as serine...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge